Open AccessAnalysis of 12 Months Clinical Outcomes Associated with Implantation of Ultrathin (60 μm) Bare Metal Stent in an Unselected Real-world Population with Coronary Artery Disease
Author(s) -
Otikunta An,
Hosad Uk,
Reddy Yvs,
E. Srikanth,
R. Srinivas,
Rajeev Garg,
Lobo Ll
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/24767.9896
Subject(s) - mace , medicine , restenosis , clinical endpoint , myocardial infarction , stent , coronary artery disease , bare metal stent , surgery , incidence (geometry) , population , cardiology , target lesion , drug eluting stent , clinical trial , percutaneous coronary intervention , physics , environmental health , optics
In the era of drug-eluting stents, Bare Metal Stent (BMS) has worked its way up to be recognized in several indications. Moreover, literature suggests that strut thickness has been directly related to the restenosis rate.